Old Web
English
Sign In
Acemap
>
Paper
>
Approved Agents in the Relapsed or Refractory Setting, Excluding Brentuximab Vedotin
Approved Agents in the Relapsed or Refractory Setting, Excluding Brentuximab Vedotin
2021
Helen Ma
Owen A. OConnor
Keywords:
Oncology
Medicine
Refractory
Brentuximab vedotin
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
91
References
0
Citations
NaN
KQI
[]